Flaxseed Oil — Product Application Guide
1. Fatty Acid Profile & Nutritional Significance
1.1 Typical Fatty Acid Composition
| Fatty Acid |
Symbol |
Typical Range (%) |
Nutritional Role |
| α-Linolenic acid (ALA) |
C18:3 n-3 |
50–60 |
Omega-3 precursor to EPA/DHA (conversion ~5–15%); cardiovascular, anti-inflammatory |
| Linoleic acid (LA) |
C18:2 n-6 |
14–19 |
Omega-6 essential fatty acid; skin barrier function |
| Oleic acid |
C18:1 n-9 |
13–20 |
Monounsaturated; heart health, oxidative stability |
| Palmitic acid |
C16:0 |
5–7 |
Saturated (minor) |
| Stearic acid |
C18:0 |
3–5 |
Saturated (minor) |
| Others (C14:0, C20:0, C18:1 n-7) |
— |
<2 |
Trace |
Nutritional highlights:
- Highest plant-based ALA content (50–60%) — superior to chia (30–35%) and perilla (55–65%).
- Omega-6:Omega-3 ratio: ~0.3:1 (exceptional, far below typical Western diet ratio of 15:1).
- Provides ~120 kcal per tablespoon (14 g), with 9 g ALA.
- Contains natural lipophilic antioxidants: γ-tocopherol (180–250 mg/kg), β-carotene (trace), chlorophyll.
1.2 Physicochemical Properties
| Property |
Value |
| Refractive index (20 °C) |
1.479–1.484 |
| Specific gravity (20 °C) |
0.927–0.937 |
| Iodine value |
170–200 |
| Saponification value |
188–196 |
| Unsaponifiable matter |
0.7–1.5% |
| Smoke point |
107–110 °C (unrefined); 130–150 °C (refined) |
| Peroxide value (fresh) |
<2 mEq O₂/kg |
Note: Unrefined (cold-pressed) flaxseed oil has a low smoke point and is unsuitable for frying. Refined flaxseed oil has slightly higher thermal tolerance but still <150 °C.
2. Applications
2.1 Dietary Supplements
| Form |
Usage |
Functional Benefit |
Processing Considerations |
| Softgels |
500–1,500 mg per capsule; 1–3 capsules/day (1–4.5 g ALA/day) |
Convenient ALA delivery; stable against oxidation when encapsulated; masking of fishy notes |
Use N₂-blanketed filling; gelatine or vegan (pullulan/HPMC) shells; add natural antioxidants (rosemary extract 200–500 ppm, tocopherols 500–1,000 ppm) to oil phase; encapsulate at ≤30 °C. Avoid metal catalyst contact (iron, copper). |
| Liquid oil |
10–15 mL (1 tbsp)/day; sold in amber/dark glass or PET |
High ALA per dose; flexible dosing; natural flavour acceptable to some consumers |
Purge headspace with N₂; recommend refrigeration after opening; use baffle-cap (drip-free) closure; incorporate vitamin E (400 IU/100 mL) as surface-active antioxidant |
| Powdered / spray-dried |
20–50% oil load on carrier; 5–10 g powder/serving |
Masked flavour; easier incorporation into dry blends; shelf-stable at ambient |
Spray-dry with maltodextrin (DE 10–15) + modified starch (Capsul®, Hi-Cap®) at 1:3 oil:carrier ratio; inlet 160–180 °C, outlet 70–80 °C; add ascorbyl palmitate 0.1% in oil phase; use SiO₂ anticaking at 1–2% |
| Emulsion (liquid shot) |
5–10 mL oil equivalent; pre-emulsified with gum arabic/lecithin |
Improved bioavailability vs bulk oil; palatable in flavoured sachets |
High-pressure homogenisation (500–800 bar); droplet size ≤2 µm; pH 3.5–4.5; sweeten with stevia/erythritol |
2.2 Salad Dressings & Mayonnaise
| Product |
Usage Level (%) |
Benefit |
Formulation Notes |
| Vinaigrette |
30–60 (of oil phase) |
ALA enrichment; mild nutty flavour; blends well with wine vinegar/citrus |
Must be consumed fresh or bottled with antioxidant system; may blend with high-oleic sunflower oil (50:50) for stability |
| Creamy dressings |
15–30 (of total fat) |
Omega-3 boost; emulsification with egg yolk or mustard |
Use refined oil for lighter colour; add EDTA (75 ppm) to chelate pro-oxidant metals; pasteurise at 65 °C/30 min max |
| Mayonnaise |
20–50 (of total oil) |
ALA fortification; maintains emulsion stability with egg yolk |
Replace up to 50% of soy/canola oil; add rosemary extract 300 ppm + tocopherols 200 ppm; homogenise at moderate shear; pH 3.5–4.0 |
2.3 Functional Foods
| Category |
Usage Level (%) |
Benefit |
Notes |
| Yoghurt & dairy |
1–3 |
ALA fortification; creamy mouthfeel |
Add post-fermentation/culturing; emulsify with WPI (2:1 oil:protein) before blending; use refined oil to avoid flavour interference |
| Smoothies & RTD beverages |
1–2.5 |
ALA delivery; additional nutritional positioning |
High-shear homogenisation essential; add gum arabic 1% + lecithin 0.5% as emulsifiers; UHT 135 °C/4 s is acceptable (ALA loss <5%) |
| Nut/seed butters |
2–5 |
Omega-3 enrichment (over base ALA content); improved spreadability |
Cold-blend to avoid warming; add mixed tocopherols 500 ppm to bulk oil before blending |
| Infant formula |
Oil blend component (10–30% of fat phase) |
ALA source for brain & retinal development; ALA:LA ratio matters (1:2–1:5 optimal per Codex) |
Must meet Codex Alimentarius Stan 72-1981; ALA minimum 50 mg/100 kcal; LA minimum 300 mg/100 kcal; use RBD (refined, bleached, deodorised) oil; peroxide value ≤1 mEq O₂/kg; anisidine value ≤10 |
| Butter/margarine spreads |
10–25 |
ALA enrichment; soft spread texture at refrigeration |
Must be fully hydrogenated-free; emulsion stability requires mono-diglycerides (0.3–0.5%); package in O₂-barrier tubs |
| Parameter |
Requirement |
| ALA content |
min 50 mg/100 kcal (Codex); EFSA recommends min 100 mg/100 kcal |
| LA:ALA ratio |
5:1 – 15:1 (Codex); ideal 3:1 – 6:1 for balanced conversion |
| Maximum ALA from flax oil |
Up to 30% of fat phase (balance from vegetable oils, algal DHA) |
| Oil quality |
Peroxide value ≤1.0, anisidine value ≤10, free fatty acids ≤0.1% as oleic |
| Antioxidant |
Mixed tocopherols ≤300 mg/kg final product; ascorbyl palmitate ≤200 mg/kg |
| DHA synergy |
Co-blend with algal oil (100–160 mg DHA/100 kcal) supports ALA→DHA conversion via substrate sparing |
| Processing |
Deodorise at 180–200 °C/60 min (removes volatile off-flavours, minimal ALA loss with short-path deodorisation) |
3. Stability Challenges & Antioxidant Strategies
3.1 Oxidation Mechanisms
Flaxseed oil's high ALA content (three double bonds, bis-allylic methylenes) makes it highly susceptible to autoxidation.
| Oxidation Phase |
Chemistry |
Sensory Threshold |
| Initiation |
Abstraction of bis-allylic H → alkyl radical (R•) |
Odourless |
| Propagation |
R• + O₂ → ROO• → ROOH (hydroperoxides) |
Odourless (PV <10 mEq/kg) |
| Secondary (rancidity) |
Hydroperoxide decomposition → aldehydes (hexanal, propanal, 2,4-heptadienal), ketones, alcohols |
Fishy, painty, grassy (hexanal >1 ppm) |
| Termination |
Radical recombination → non-radical end products |
Bitter, astringent |
Key degradation volatiles: Hexanal, (E)-2-hexenal, (E,E)-2,4-heptadienal, propanal, pentanal.
3.2 Antioxidant Strategies
| Antioxidant |
Recommended Level |
Mechanism |
Best For |
| Mixed tocopherols (natural: γ, δ, α) |
500–1,000 ppm in oil phase |
Chain-breaking (H-donation); synergises with ascorbyl palmitate |
All applications; GRAS, clean label |
| Rosemary extract (carnosic acid, carnosol) |
200–500 ppm in oil; 500–2,000 ppm in emulsion |
Radical scavenging + metal chelation; heat-stable |
Baked goods, dressings, emulsified systems |
| Ascorbyl palmitate |
100–300 ppm |
Synergist — regenerates tocopherols; oxygen scavenger |
Mayonnaise, spreads, infant formula |
| Green tea extract (EGCG) |
50–200 ppm |
Potent radical scavenger (ORAC >10,000 µmol TE/g) |
Beverages, chilled emulsions |
| Citric acid / EDTA |
50–200 ppm |
Metal chelation (sequesters Fe²⁺, Cu²⁺) |
Aqueous phase in emulsions; synergist |
| Lecithin |
0.5–2% |
Emulsifier + synergist with tocopherols; surface-active antioxidant |
Emulsions, dressings, dairy blends |
| N₂ flushing |
— |
Oxygen displacement in headspace |
Softgels, bottled oil, bulk storage |
| Vitamin E (α-tocopherol) |
200–400 IU/100 mL finished product |
Chain-breaking; regenerative synergy with ascorbate |
Liquid oils, infant formula |
Optimal combination (proven efficacy in flax oil):
- Oil phase: Mixed tocopherols (600 ppm) + rosemary extract (300 ppm) + ascorbyl palmitate (200 ppm)
- Aqueous phase (emulsions): EDTA (75 ppm) + citric acid (100 ppm)
- Processing: N₂ blanket throughout; store ≤20 °C; protect from light
3.3 Accelerated Stability Data
| Condition |
Time to PV >10 (mEq/kg) |
Effect of 600 ppm mixed tocopherols |
| 20 °C (dark) |
6–9 months |
Extends to 12–18 months |
| 40 °C (dark, Rancimat) |
14–18 h induction time (bare oil) |
Extends to 28–36 h with antioxidants |
| 63 °C (Schaal oven) |
4–6 days |
Extends to 10–14 days |
| Light exposure (500 lux, 25 °C) |
2–3 days |
Extends to 5–8 days with opaque packaging |
4.1 Usage Levels by Application
| Application |
Typical Use Level |
ALA Contribution (approx.) |
| Softgels (1,000 mg) |
1,000 mg/cap |
550 mg ALA/cap |
| Liquid oil (daily dose) |
15 mL (13.8 g) |
7.6 g ALA |
| Salad dressing (30 g serving, 50% flax oil) |
15 g oil/serving |
8.3 g ALA |
| Mayonnaise (15 g serving, 30% flax oil) |
4.5 g oil/serving |
2.5 g ALA |
| Yoghurt (100 g, 3% flax oil) |
3 g oil/serving |
1.7 g ALA |
| Infant formula (100 kcal, 30% of fat = 1.5 g flax oil) |
1.5 g oil/100 kcal |
0.82 g ALA/100 kcal |
| Functional beverage (200 mL, 2% oil) |
4 g oil/serving |
2.2 g ALA |
| Snack bar (40 g, 5% oil) |
2 g oil/bar |
1.1 g ALA |
4.2 Synergy with Other Oils
| Oil Blend |
Ratio (flax:other) |
Benefit |
| Flax + fish oil (EPA+DHA) |
3:1 to 1:1 |
Provides ALA as precursor + pre-formed EPA/DHA for immediate benefit; improved omega-3 index |
| Flax + algal DHA |
4:1 to 2:1 |
DHA supports ALA→DHA conversion pathway; vegetarian EPA/DHA alternative; superior oxidative stability vs fish oil |
| Flax + high-oleic sunflower |
1:1 to 1:3 |
Improves oxidative stability significantly; lowers polyunsaturated load; better sensory profile for cooking applications |
| Flax + MCT oil |
1:1 |
Quick energy + ALA; improves bioavailability via micelle formation; good for sports nutrition |
| Flax + borage oil (GLA) |
3:1 |
Omega-3 + Omega-6 (GLA) synergy for anti-inflammatory effect; skin health applications |
5. Oxidative Stability in Finished Products
| Product Type |
Expected Shelf Life (ambient) |
Key Control Points |
PV Limit at End of Shelf Life |
| Softgels (opaque blister) |
24–30 months |
N₂ flush, low moisture (<1%), light barrier |
≤10 mEq/kg |
| Liquid oil (unopened, refrigerated) |
12–18 months |
Dark bottle, N₂ headspace, <20 °C |
≤5 mEq/kg |
| Liquid oil (after opening, refrigerated) |
6–8 weeks |
Keep capped, N₂-spray each use |
≤15 mEq/kg (recommend ≤10) |
| Spray-dried powder (foil pouch) |
18–24 months |
aw <0.25, O₂ scavenger sachet, <25 °C |
≤8 mEq/kg (extracted oil) |
| Salad dressing (bottled, <4 °C) |
6–9 months |
Emulsion droplet size <1 µm, EDTA chelation, pH <4.0 |
≤5 mEq/kg oil phase |
| Mayonnaise (ambient, sealed) |
6–9 months |
Acid pH (3.5–4.0), egg yolk antioxidants, metal-free processing |
≤5 mEq/kg oil phase |
| Infant formula (sealed tin, ambient) |
18–24 months |
N₂ flush, vitamin E addition, PV ≤1 at production |
≤3 mEq/kg oil phase |
| Yoghurt (chilled, sealed) |
21–28 days |
Post-fermentation addition, refrigerated ≤6 °C |
≤5 mEq/kg oil phase |
| Functional beverage (UHT, aseptic) |
9–12 months |
N₂ headspace, tocopherols + rosemary, opaque Tetra Pak |
≤5 mEq/kg oil phase |
| Nut butter (ambient, sealed) |
9–12 months |
Tocopherol addition, <25 °C, O₂ barrier jar |
≤5 mEq/kg oil phase |
6. Label Claims
6.1 Omega-3 (ALA) Claims
| Claim |
EU (Reg. 1924/2006 + 116/2010) |
US (FDA) |
China (GB 28050-2011, GB 28050-2024 draft) |
| Source of omega-3 ALA |
≥0.3 g ALA/100 g or ≥0.15 g ALA/100 kcal |
"Good source" → ≥0.32 g ALA/Serving (per DRV rounding rules); or "Contains" language for ≥2.5 g ALA/serving |
≥0.3 g ALA/100 g (solid) or ≥0.15 g ALA/100 g (liquid) |
| High in omega-3 ALA |
≥0.6 g ALA/100 g or ≥0.3 g ALA/100 kcal |
"Excellent source" → use quantitative disclosure ≥0.65 g ALA/serving; or "High" ≥5 g ALA/serving |
≥0.6 g ALA/100 g (solid) or ≥0.3 g ALA/100 g (liquid) |
| Omega-3 (ALA) health claim (qualified) |
Not authorised; EFSA rejected ALA heart health claim in 2011 (insufficient evidence) |
Qualified health claim (2014): "Supportive but not conclusive research shows that eating 1.5 tsp (7 g) of flax oil per day may reduce the risk of coronary heart disease" — requires FDA disclaimer |
Not currently permitted; structure–function claims may be used |
6.2 Nutrient Reference Values (NRV / %DV)
| Market |
ALA NRV/DV |
Notes |
| EU |
2 g ALA/day (EFSA DRV) |
79% NRV per 15 mL serving (approx. 7.6 g ALA) |
| US |
1.6 g ALA/day (DRI for men); 1.1 g ALA/day (women) |
475–690% DV per 15 mL serving |
| China |
1.5 g ALA/day (DRIs 2013 — adults) |
507% DV per 15 mL serving |
| Codex |
— |
No NRV established for ALA individually; omega-3 as sum |
6.3 Example Claim Wording
EU:
- "Flaxseed oil is a source of omega-3 (α-linolenic acid). Contains 7.6 g ALA per 15 mL serving (379% of the reference intake of 2 g/day)."
- "High omega-3 content. Each 7.5 mL serving provides 3.8 g ALA, meeting the claim threshold of 0.6 g/100 g."
US:
- "Excellent source of ALA omega-3. One serving (1 tbsp) contains 7.6 g of alpha-linolenic acid (ALA), which is 475% of the Daily Value."
- "Qualified health claim: Supportive but not conclusive research shows that eating about 1½ teaspoons (7 grams) of flaxseed oil per day may reduce the risk of coronary heart disease due to the ALA content. [See nutrition information for total fat and saturated fat content.]"
China:
- "高α-亚麻酸 (High in α-linolenic acid). 每15毫升含7.6克α-亚麻酸 (Contains 7.6 g ALA per 15 mL)."
- "含ω-3脂肪酸 (Contains omega-3 fatty acids). 每100克含50克α-亚麻酸 (Contains 50 g ALA per 100 g)."
7. Regulatory Limits for ALA Claims per Market
7.1 Maximum Permitted Levels (where applicable)
| Market |
Regulation |
ALA Max Intake Guideline |
Notes |
| EU |
Reg. 1924/2006 (nutrition claims); EFSA DRV 2010 |
UL: No established upper limit; typical supplement ≤5 g ALA/day; EFSA DRV 2 g/day |
Claims subject to nutrient profiles per Reg. 1924/2006 Art. 4 (not yet adopted for fats as of 2026). ALA content must be declared in g/100 g or g/100 mL. |
| US |
21 CFR 101.36 (supplements); 101.9 (foods); FDA DRI 2023 |
ALA DV = 1.6 g/day (DRI); no established UL. GMP ≤45 mg/kg b.w. recommendation from some authorities is for total n-3 (EPA+DHA+ALA). |
Quantitative disclosure required when product contains ≥5 g total fat/serving (as %DV). Flax oil supplement labels must include "Keep refrigerated" statement if PV risk. |
| China |
GB 28050-2011; GB 28050-2024 (draft); GB 16740-2014 (supplements) |
ALA DRV = 1.5 g/day. Formula foods: ALA max ≤1.8% of total energy (infant foods GB 10765-2021). |
Health food registration may be needed for >3 g ALA/day supplements. Label must declare ALA in g/100 g and as %NRV. |
| Japan |
Nutrition Labelling Standards (CAA 2015); Foods for Specified Health Uses (FOSHU) |
ALA UL not established. FOSHU claim for flax oil: "Omega-3 (ALA) contributes to maintenance of blood cholesterol levels." |
Flax oil can be marketed as FOSHU with approved label if clinical evidence submitted. General food label must list ALA as "α-リノレン酸" in fat breakdown. |
| Australia/NZ |
FSANZ Standard 1.2.7; Standard 2.9.1 (infant formula) |
ADI 3 g ALA/day (no fixed UL). Infant formula: ALA ≥50 mg/100 kJ (Codex-aligned). |
ALA nutrition content claims: "source" ≥200 mg/serving; "good source" ≥500 mg/serving; "high" ≥1,000 mg/serving. |
7.2 Warning/Advisory Statement Requirements
| Market |
Required Statement |
| US (supplements) |
"Keep out of reach of children. Store in a cool, dry place. Refrigerate after opening." (recommended best practice) |
| EU (supplements >2 g ALA/day) |
"Do not exceed recommended daily dose." "Food supplements should not be used as a substitute for a varied diet." |
| China (health food registration) |
"本品不能代替药物" (This product cannot replace medication). For oils: "开瓶后需冷藏" (Refrigerate after opening). |
| Canada |
"Do not use if you are taking anticoagulant therapy or have a bleeding disorder." (risk-based advisory for >3 g ALA/day) |
8. Processing & Handling Guidelines
- Extraction: Cold-press at ≤40 °C; expeller-press only (no solvent); filter through 1–5 µm to remove sediment.
- Storage of bulk oil: Stainless steel tanks (not iron/copper); N₂ blanket; <15 °C; protected from light.
- Deodorisation (optional): Short-path/steam distillation at 150–180 °C, 1–3 h, with citric acid (0.05%) added post-deodorisation to chelate metals.
- Packaging: Amber or dark green glass; multilayer PET with UV absorber; foil-lined bag-in-box for bulk.
- Shelf life monitoring: Track PV, p-anisidine value, hexanal (GC headspace), and sensory panel (fishy/painty score).